Sales rise 63.90% to Rs 130.30 crore
Net profit of Senores Pharmaceuticals rose 83.88% to Rs 19.73 crore in the quarter ended June 2025 as against Rs 10.73 crore during the previous quarter ended June 2024. Sales rose 63.90% to Rs 130.30 crore in the quarter ended June 2025 as against Rs 79.50 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 130.30 | 79.50 | 64 |
OPM % | 26.22 | 26.82 | - |
PBDT | 32.48 | 16.98 | 91 |
PBT | 26.49 | 13.46 | 97 |
NP | 19.73 | 10.73 | 84 |
Powered by Capital Market - Live News